Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amphastar Pharma (NQ: AMPH )

29.39 +0.14 (+0.48%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 29, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 239,002
Open 29.27
Bid (Size) 29.10 (1)
Ask (Size) 29.70 (1)
Prev. Close 29.25
Today's Range 29.25 - 29.62
52wk Range 19.21 - 44.46
Shares Outstanding 48,331,186
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Amphastar Pharmaceuticals to Present at the Piper Sandler 34th Annual Healthcare Conference
Via ACCESSWIRE
Can This Company's Positive Results For Psychedelic Combination Treatment Provide Hope For Alcohol And Cocaine Addiction Problems?
There is a high probability that you may know someone battling some form of addiction. Whether it’s a problem with opioids, alcohol, cocaine, or even using pain meds, an unchecked addiction can be... 
Via Benzinga

Performance

YTD
+27.89%
+27.89%
1 Month
-4.89%
-4.89%
3 Month
-3.39%
-3.39%
6 Month
-20.87%
-20.87%
1 Year
+50.87%
+50.87%

More News

Read More
Amphastar Pharmaceuticals to Present at the 2022 Jefferies London Healthcare Conference
Via ACCESSWIRE
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2022
Via ACCESSWIRE
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 7, 2022
Via ACCESSWIRE
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2022
Via ACCESSWIRE
Intercept Pharmaceutical Stock Sees RS Rating Rise To 91
Via Investor's Business Daily
Recursion Pharma Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
Via Investor's Business Daily
7 Safe Stocks to Rely on When the Market Swerves
Via InvestorPlace
Amphastar Pharmaceuticals to Present at the Wells Fargo 2022 Healthcare Conference
Via ACCESSWIRE
Amphastar Pharmaceuticals's Return on Invested Capital Overview
Via Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Amphastar Pharmaceuticals Receives FDA Approval for Epinephrine Pre-Filled Syringes
Via ACCESSWIRE
Stock Market Rally Rises On Inflation Data; Nvidia, Micron, Tesla, Disney In Focus: Weekly Review
Via Investor's Business Daily
Amphastar Pharmaceuticals: Q2 Earnings Insights
Via Benzinga
Amphastar, Syndax Top Second-Quarter Estimates, But Runaway Biotechs At A Standstill
Via Investor's Business Daily
Kura Oncology Stock Joins Rank Of Stocks With RS Ratings Over 90
Via Investor's Business Daily
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2022
Via ACCESSWIRE
Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022
Via Benzinga
Keep Amphastar Pharmaceuticals Stock On Your Watch List Ahead Of Earnings
Via Investor's Business Daily
Amphastar Receives FDA Approval for Vasopressin
Via ACCESSWIRE
Amphastar Receives FDA Approval for Vasopressin
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Exposures Product Safety
Crispr Therapeutics Stock Shows Rising Price Performance With Jump To 94 RS Rating
Via Investor's Business Daily
Biotech Hasn't Been This Blazing Hot Since Early 2021 — Here Are The Top 5
Via Investor's Business Daily
Prometheus Biosciences Stock Shows Rising Relative Strength
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.